Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes

Unknown buyer

Published
10 February 2027
Added to Open Tenders
10 July 2026
Submission deadline
21 September 2027
Award decision
Not yet published

✨ AI summary

The buyer is unknown for phase 1 clinical trials testing biomarker-guided medicines. These trials are for patients with rare or very rare cancers or cancer subtypes. The goal is to test multi-modal treatment interventions.

Original notice

View on source ↗

Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes

Reproduced verbatim from the official notice — only the wording is the source's; we split it into sections for readability.

Reference imagery

Illustrative only — not photos of this specific project.

📋Uncategorised

📄Public contract

📍Portugal

Unknown buyer—

Industrial processes and equipment for innovative, reliable and scalable tandem technologies (EUPI-PV Partnership)

Unknown buyer—

Community of practice - Data-Driven Decision-Making in Energy

Unknown buyer—

Advanced Distribution Management Systems (ADSM) for more efficient and flexible distribution grids

Unknown buyer—